← Назад

Progressive non-fluent aphasia

ORPHA:100070DiseaseMultigenic/multifactorial, Not applicableAdult

Ассоциированные гены (8)

TMEM106B
transmembrane protein 106B
Major susceptibility factor in
OMIM: 613413
PSEN1
presenilin 1
Disease-causing germline mutation(s) in
OMIM: 104311
CHMP2B
charged multivesicular body protein 2B
Major susceptibility factor in
OMIM: 609512
TREM2
triggering receptor expressed on myeloid cells 2
Major susceptibility factor in
OMIM: 605086
VCP
valosin containing protein
Major susceptibility factor in
OMIM: 601023
MAPT
microtubule associated protein tau
Major susceptibility factor in
OMIM: 157140
GRN
granulin precursor
Major susceptibility factor in
OMIM: 138945
C9ORF72
C9orf72-SMCR8 complex subunit
Major susceptibility factor in
OMIM: 614260

Фенотипы (32)

Очень частый (80–99%)9
HP:0000474Thickened nuchal skin fold
HP:0001268Mental deterioration
HP:0002145Frontotemporal dementia
HP:0002354Memory impairment
HP:0002381Aphasia
HP:0006892Frontotemporal cerebral atrophy
HP:0006977Grammar-specific speech disorder
HP:0007112Temporal cortical atrophy
HP:0030391Spoken Word Recognition Deficit
Частый (30–79%)7
HP:0000716Depression
HP:0000739Anxiety
HP:0002186Apraxia
HP:0002500Abnormal cerebral white matter morphology
HP:0010523Alexia
HP:0011204EEG with continuous slow activity
HP:0012658Abnormal brain FDG positron emission tomography
Периодический (5–29%)12
HP:0000708Atypical behavior
HP:0000711Restlessness
HP:0000751Personality changes
HP:0001300Parkinsonism
HP:0002071Abnormality of extrapyramidal motor function
HP:0002300Mutism
HP:0002366Abnormal lower motor neuron morphology
HP:0002427Motor aphasia
HP:0002446Astrocytosis
HP:0010526Dysgraphia
HP:0030223Perseveration
HP:0100256Senile plaques
Исключён (0%)4
HP:0001297Stroke
HP:0002185Neurofibrillary tangles
HP:0030692Brain neoplasm
HP:0100315Lewy bodies

Эпидемиология (2)

Point prevalence
1-9 / 100 000
Europe
Annual incidence
1-9 / 1 000 000
Europe

Лекарства и терапия

Источник: Open Targets Platform (в реальном времени)

Клинические исследования

Источник: ClinicalTrials.gov (в реальном времени)

Внешние ресурсы